Avoid common mistakes on your manuscript.
Dear Reader,
Welcome to the final issue of Targeted Oncology for 2021.
I wish to reflect on this year’s achievements, and to thank all those who have contributed their time and effort to guarantee the quality of the content published in the journal.
In 2021, over 70 articles have been published. The most popular of these in terms of downloads from SpringerLink have been:
The high quality of content published in Targeted Oncology has been reflected in the most recent impact factor of 4.493 and CiteScore™ of 7.3. Further, Targeted Oncology has published content in a timely manner, with an average time from submission to first decision of 15 days.
The COVID-19 pandemic has continued to present many challenges and I would like to thank all who have contributed to ensuring the journal has thrived despite the ongoing issues.
I would like to start by thanking the authors of the articles published in Targeted Oncology over the course of 2021. The enthusiasm of all authors for their chosen fields and their willingness to contribute content to the journal are crucial for its continued success.
The quality of published articles is also testament to the diligence of the peer reviewers. I would like to acknowledge the following individuals who acted as reviewers for Targeted Oncology in the last 12 months:
Muhammad Zubair Afzal, USA
Thierry Alcindor, Canada
Lawrence Andrews, USA
Kazuhiro Araki, Japan
Hugo Arasanz Esteban, Spain
Rebecca Arend, USA
Jean Auliac, France
Kyaw Aung, USA
Aristotelis Bamias, Greece
Mark Barok, Finland
Viviana Bazan, Italy
Bertram Bengsch, Germany
Eric Bernicker, USA
Jan Bieńkiewicz, Poland
Annalen Bleckmann, Germany
Burkhard Brandt, Germany
Virginia Calvo, Spain
John Carucci, USA
Aude Charbonnier, France
Aman Chauhan, USA
Chao-Hua Chiu, Taiwan, Republic of China
Joanne Chiu, Hong Kong, China
Shih-Feng Cho, Taiwan, Republic of China
Petros Christopoulos, Germany
Pawel Chrom, Poland
Pippa Corrie, UK
Kristof Cuppens, Belgium
Nancy Davis, USA
Theo de Reijke, The Netherlands
Giovan Giuseppe Di Costanzo, Italy
Valérie Dutoit, Switzerland
Camille Evrard, France
Conrad Fernandez, Canada
Steven Fling, USA
Elisa Fontana, UK
Christos Fountzilas, USA
Masahide Fukudo, Japan
Thilo Gambichler, Germany
Pere Gascon, Spain
Prafull Ghatage, Canada
Paola Ghione, USA
Valerie Glutsch, Germany
María Teresa Gómez-Casares, Spain
Thomas Graillon, France
Alastair Greystoke, UK
Xiuwen Guan, China
David Guttery, UK
Jun Hanaoka, Japan
Simon Harrison, Australia
Alain Hendlisz, Belgium
Cinta Hierro, Spain
John Hilton, Canada
Maximilian J. Hochmair, Austria
Sarah A. Holstein, USA
Chih-Hung Hsu, Taiwan, Republic of China
Harun Ilhan, Germany
Gino In, USA
Hiroki Ishihara, Japan
Eiji Iwama, Japan
Stefan Kasper, Germany
Mustafa Khasraw, USA
Dennis Kim, Canada
Kyung Bo Kim, USA
Sang-We Kim, Republic of Korea
Heinz-Josef Klümpen, The Netherlands
Scott Chih-Hsi Kuo, Taiwan, Republic of China
Teiji Kuzuya, Japan
Ulrik Lassen, Denmark
Jae Cheol Lee, Republic of Korea
Jeeyun Lee, Republic of Korea
Joycelyn Lee, Singapore
Konstantinos Leventakos, USA
Bora Lim, USA
Chia-Chi Lin, Taiwan, Republic of China
Nan Lin, USA
Gabriella Liszkay, Hungary
Xue-Qun Luo, China
Susanne Malander, Sweden
Steven Maron, USA
Koji Matsuo, USA
Gianluca Mauri, Italy
Felicity May, UK
Bradley McGregor, USA
Pam McKay, UK
Joseph Mikhael, USA
Maria Carmen Mir, Spain
Alberto Montero, USA
Sarbajit Mukherjee, USA
Aiko Nagayama, Japan
Jayakumar Nair, USA
Masahito Nakano, Japan
Beatrice Nardone, USA
Takahito Negishi, Japan
Matthew Chau Hsien Ng, Singapore
Shin Nishio, Japan
Noboru Numao, Japan
Shuntaro Obi, Japan
Scott Okuno, USA
L’Houcine Ouafik, France
Tejas Patil, USA
Patricia Pautier, France
Tycel Phillips, USA
Camelia Quek, Australia
Renju Raj, USA
Emanuel Raschi, Italy
Isabelle Ray-Coquard, France
Joshua Richter, USA
Lorenza Rimassa, Italy
Daniele Rossini, Italy
Eduard Roussel, Belgium
Piotr Rutkowski, Poland
Kazutaka Saito, Japan
Martin Salzmann, Germany
Hironaga Satake, Japan
Yuki Sato, Japan
Maria Scavo, Italy
Hans-Ulrich Schildhaus, Germany
Manuela Schmidinger, Austria
Scott Schuetze, USA
Cesar Serrano, Spain
Neal Shore, USA
Darren Sigal, USA
Nicola Silvestris, Italy
Hiroshi Soda, Japan
Corey Speers, USA
Srikala Sridhar, Canada
Chunxia Su, China
Kenichi Suda, USA
Daisuke Takahari, Japan
Junko Tanizaki, Japan
Tetsu Tomonari, Japan
Nikolaos Tsoukalas, Greece
Akihiro Tsuboi, Japan
Hiroshi Ureshino, Japan
Anke van den Berg, The Netherlands
Brian van Tine, USA
Naveen Vasudev, UK
Kathelijn Versteeg, The Netherlands
Nikolaus Wagner, Germany
Yufeng Wang, USA
Muzamil Want, USA
David Waterhouse, USA
Marcel Wiesweg, Germany
Min Yan, China
Rinat Yerushalmi, Israel
Kan Yoenmori, Japan
Changhoon Yoo, Republic of Korea
Tatsuya Yoshida, Japan
Tian Zhang, USA
David Ziegler, Australia
I also very grateful to the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy, and processes:
James Armitage, University of Nebraska Medical Center, Omaha, NE, USA
James Berenson, Institute for Myeloma and Bone Cancer Research, West Hollywood, CA, USA
Jean-Yves Blay, University Claude Bernard Lyon I, Lyon, France
Tomas Buchler, Charles University and Thomayer Hosptial, Prague, Czech Republic
Ann-Lii Cheng, National Taiwan University, Taipei, Taiwan, Republic of China
Fortunato Ciardiello, Second University of Naples, Naples, Italy
Jayesh Desai, The Royal Melbourne Hospital, Melbourne, VIC, Australia
Sandrine Faivre, Beaujon University Hospital, Clichy, France
Giuseppe Giaccone, Weill Cornell Medicine, New York, NY, USA
Petros Grivas, University of Washington, Seattle, WA, USA
Balazs Halmos, Montefiore Medical Center, New York, NY, USA
Gabriel Hortobagyi, Houston, TX, USA
Christian Jackisch, Sana Klinikum, Offenbach, Germany
V. Craig Jordan, MD Anderson, Houston, Texas, USA
John Kirkwood, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Heinz-Josef Lenz, University of Southern California, Los Angeles, CA, USA
Teresa Macarulla, Vall d’Hebron University Hospital, Barcelona, Spain
Mark McKeage, University of Auckland, Auckland, New Zealand
Alain Mita, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA
Monica Mita, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA
Jean-François Morère, Hôpital Avicenne, Paris-Nord, France
Athanasios Papavassiliou, National and Kapodistrian University of Athens, Athens, Greece
Camilo Porta, IRCCS San Matteo University Hospital Foundation, Pavia, Italy
Timothy Price, The Queen Elizabeth Hospital, Adelaide, SA, Australia
Shukui Qin, Chinese Society of Clinical Oncology, Nanjing, China
Eric Raymond, Groupe Hospitalier Paris Saint-Joseph, Paris, France
Richard Riedel, Duke University, Durham, NC, USA
Olivier Rixe, Quantum Santa Fe, Santa Fe, NM, USA
Helen Rizos, Macquarie University, North Ryde, NSW, Australia
Nicole Shonka, University of Nebraska Medical Center, Omaha, NE, USA
Denis Soulières, Centre Hospitalier de l’Université de Montréal, Montréal, Québec, Canada
Yu Sunakawa, St. Marianna University School of Medicine, Kawasaki, Japan
Eric Van Cutsem, University Hospitals Leuven, Leuven, Belgium
In terms of other important company initiatives, the Springer Nature ‘Sustainable Development Goals (SDG) Programme’ is aiming to connect researchers who are tackling the world’s toughest challenges with practitioners in policy and business, while the ‘Women in Science’ initiative aims to help empower more women scientists to achieve scientific excellence. Finally, I am delighted to inform you that Springer Nature is now carbon neutral for its direct operations (offices, fleet, and flights) and earlier this year signed The Climate Pledge, making a commitment to be Net Zero carbon by 2040.
Returning to Targeted Oncology, the editorial program for 2022 is well under way, and I am looking forward to bringing you many high-quality and authoritative articles in the field of Targeted Oncology over the coming year.
I thank you for your continued support.
With best wishes,
Martin Chopra
About this article
Cite this article
Acknowledgement to Referees. Targ Oncol 16, 697–700 (2021). https://doi.org/10.1007/s11523-021-00851-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11523-021-00851-0